lotrafiban has been researched along with Stroke in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Salam, AM | 1 |
Amarenco, P; Califf, R; Chan, R; Davis, S; Diener, HC; Easton, JD; Ferguson, J; Fitzgerald, D; Graffagnino, C; Granett, J; Harrington, R; Ilson, B; Koudstaal, PJ; Samuels, R; Shuaib, A; Theroux, P; Topol, EJ; Van de Werf, F; Willerson, JT | 1 |
SoRelle, R | 1 |
1 trial(s) available for lotrafiban and Stroke
Article | Year |
---|---|
Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial.
Topics: Administration, Oral; Adolescent; Arterial Occlusive Diseases; Benzodiazepines; Double-Blind Method; Drug Evaluation; Female; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Myocardial Ischemia; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Research Design; Secondary Prevention; Stroke | 2000 |
2 other study(ies) available for lotrafiban and Stroke
Article | Year |
---|---|
Is there a role for oral blockade of platelet glycoprotein IIb/IIIa receptors in coronary and cerebrovascular disease?
Topics: Administration, Oral; Benzodiazepines; Coronary Disease; Humans; Piperidines; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stroke | 2003 |
SmithKline Beecham halts tests of lotrafiban, an oral glycoprotein IIb/IIIa inhibitor.
Topics: Administration, Oral; Benzodiazepines; Clinical Trials, Phase III as Topic; Hemorrhage; Humans; Myocardial Infarction; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Treatment Outcome | 2001 |